29/04/2019 12:30:00

Block Listing Interim Review

BLOCK LISTING SIX MONTHLY RETURN

 (Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date: 29 April 2019

Name of applicant:Summit Therapeutics plc
Name of scheme:2005 EMI Scheme
Period of return:From:30 Sep 2018To:31 Mar 2019
Balance of unallotted securities under scheme(s) from previous return:4,402,293

Plus:

  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Zero

Less:

  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Zero

Equals:

  Balance under scheme(s) not yet issued/allotted at end of period:

776,756

Name of applicant:Summit Therapeutics plc
Name of scheme:2016 Long Term Incentive Plan
Period of return:From:30 Sep 2018To:31 Mar 2019
Balance of unallotted securities under scheme(s) from previous return:4,196,863

Plus:

  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Zero

Less:

  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Zero

Equals:

  Balance under scheme(s) not yet issued/allotted at end of period:

4,196,863

Name of contact:Richard Pye
Telephone number of contact:+44 (0)1235 443951

This figure has been reduced since the last block list review to reflect the number of share options that remain in existence under the 2005 EMI Scheme. This change is due to the voluntary surrender of share options, as announced by regulatory information service on 8 October 2018, that included options awarded under the 2005 EMI Scheme. Other share options issued under the 2005 EMI Scheme lapsed due to employees leaving the Company and these changes are also reflected in the reduced figure. No new share options will be issued under the 2005 EMI Scheme.

Summit Master_rgb_png.png

Related content
05 Sep - 
Summit Presented In Vivo Proof of Concept Data for Targ..
04 Sep - 
Summit Therapeutics to Participate in Upcoming Investor..
01 Aug - 
Summit Therapeutics to Present at the Canaccord Genuity..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
UPDATE - Yoko Ono and John Lennon Educational Tour Bus “Imagine A City With No Gun Violence!”
2
Translate Bio Announces Pricing of Public Offering of Common Stock
3
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SAExploration Holdings, Inc. - SAEX
4
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Pluralsight, Inc. - PS
5
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR

Related stock quotes

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 September 2019 06:47:05
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190829.2 - EUROWEB1 - 2019-09-18 07:47:05 - 2019-09-18 06:47:05 - 1000 - Website: OKAY